Aptevo Therapeutics Inc. (APVO) stock

APVONasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 6/30

$0.59−0.07 (-10.00%)

Close on Nov 13, 2026Market cap $1.07MP/E –Yield –

Aptevo Therapeutics statistics

60 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Q3 FY2026, expected soon
Last ex-dividend date: No dividends
Fundamentals through: Jun 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $1.07M; $272.32M
Enterprise Value: -$8.73M; $146.23M
PB Ratio: 0.18; 2.00
P/TBV Ratio: 0.18; 2.22

Share statisticsIndustry

Shares Outstanding: 2M; 58M
Shares Change (QoQ): 17.9%; 0.50%
Float: 2M; 49M
Shares Held by Insiders: 14.3%; 11.7%
Shares Held by Institutions: 2.80%; 56.4%

Short sellingIndustry

Short Interest: 71,260; –
Short Interest Change: -26.2%; -0.80%
Short % of Float: 4.61%; 9.01%
Short % of Shares Outstanding: 3.95%; 6.30%
Days to Cover: 1.93; 5.15

Stock price statisticsIndustry

52-Week High: $27.72; –
52-Week Low: $0.59; –
20-Day Moving Average: $1.28; –
50-Day Moving Average: $1.59; –
200-Day Moving Average: $3.98; –
Average True Range (14): $0.14; –
Price Change (1 Week): -52.1%; -1.15%
Price Change (1 Month): -65.1%; -4.87%
Price Change (3 Months): -78.9%; -21.0%
Price Change (6 Months): -87.5%; -20.6%
Price Change (YTD): -93.7%; -23.6%
Price Change (1 Year): -97.8%; -22.4%
Price Change (3 Years): -100.0%; -29.5%
Price Change (5 Years): -100.0%; -77.9%
Price Change (10 Years): -100.0%; -65.4%
Average Volume (10 Days): 131,185; –
Average Volume (20 Days): 84,400; –
Average Volume (90 Days): 88,925; –
Relative Volume: 1.25; 0.70
Relative Strength Index (14): 11.1; 43.4
Volatility (1 Year): 96.4%; 80.1%
Beta (5 Years): 0.76; 1.07

Returns on capitalIndustry

Return on Equity (ROE): -420.3%; -49.9%
Return on Assets (ROA): -175.2%; -40.6%
Return on Capital Employed (ROCE): -288.1%; -37.9%

Financial positionIndustry

Current Ratio: 2.08; 3.30
Quick Ratio: 1.89; 2.39

EfficiencyIndustry

Profits Per Employee: -$660.20K; -$689.41K
Employee Count: 40; 74
WACC: 8.92%; 10.2%

Income statement (TTM)Industry

Operating Income: -$26.89M; -$21.37M
Net Income: -$26.41M; -$22.35M
EBITDA: -$26.69M; -$17.21M

Balance sheetIndustry

Cash & Short-Term Investments: $9.80M; $68.68M
Net Cash (Debt): $9.80M; $17.76M
Net Cash Per Share: $5.44; $0.80
Equity (Book Value): $6.04M; $53.89M
Book Value Per Share: $3.35; $1.50
Tangible Book Value: $6.04M; $27.13M
Working Capital: $5.61M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$25.34M; -$12.38M

Dividends and yieldsIndustry

Earnings Yield: -2466.8%; -21.8%
Buyback Yield: -2351.5%; -0.76%
Shareholder Yield: -2351.5%; 0.00%

Scores and fair valueIndustry

Altman Z-Score: -33.37; 0.23
Piotroski F-Score: 3; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	APVO	S&P 500	Difference	APVO per year	S&P 500 per year
1 month	-65.7%	-3.0%	−62.6 pts
3 months	-82.5%	-2.8%	−79.7 pts
Year to date	-93.7%	+11.5%	−105.2 pts
1 year	-97.7%	+13.5%	−111.2 pts
3 years	-100.0%	+77.7%	−177.7 pts	-98.2%	+21.1%
5 years	-100.0%	+72.6%	−172.6 pts	-96.1%	+11.5%
10 years	-100.0%	+308.2%	−408.2 pts	-82.2%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M APVO shares were sold short on Oct 30, 2026, down 26.2% from the previous report, or 4.61% of the shares available to trade. At recent volumes it would take 1.9 days to buy them back. Over the last 20 sessions, 43.2% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	71,260	-26.2%	36,885	1.9
Oct 15, 2026	96,527	-19.2%	50,101	1.9
Sep 30, 2026	119,457	-36.4%	69,825	1.7
Sep 15, 2026	187,942	+59.0%	336,643	1.0
Aug 31, 2026	118,188	+44.6%	61,195	1.9
Aug 14, 2026	81,745	-6.7%	33,741	2.4
Jul 31, 2026	87,627	-36.2%	19,324	4.5
Jul 15, 2026	137,249	+72.8%	165,612	1.0
Jun 30, 2026	79,436	-0.8%	23,282	3.4
Jun 15, 2026	80,080	-0.1%	36,881	2.2
May 29, 2026	80,160	-8.7%	29,937	2.7
May 15, 2026	87,845	-4.7%	58,805	1.5

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?